Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 17, 2020

View Archived Issues

scRNA-seq of Trypanosoma brucei from tsetse reveals candidates for a transmission-blocking vaccine

Anti-IL-1b platelet conjugate prevents sterile inflammation and adverse cardiac remodeling after AMI

Positive data for RECCE-327 in models of kidney and UTI infection

Sihuan Pharmaceutical initiates phase III study of anaprazole sodium in duodenal ulcer

GeneTx receives approval to initiate phase I/II study GTX-102

Phase I data presented for fosciclopirox in advanced solid tumors

Bayer presents data from phase II/III FORT-1 study of rogaratinib

Preliminary data presented from POLARIS-03 study of toripalimab in UC

Hinova Pharmaceuticals discovers new BRD4 inhibitors

High affinity nerve growth factor receptor inhibitors presented by JC Pharma

New IDO-1 inhibitors identified at Bristol-Myers Squibb

Domain Therapeutics patents mGluR4 positive allosteric modulators

Dual mu-opioid/voltage-gated calcium channels alpha2/delta-1 subunit ligands synthesized at Esteve

Ebola survivor's antibodies reveal therapeutic targets

Origin story helps ovarian cancer prognosis

Kinase, caspase play unexpected roles in NASH

MAO-A inhibitor phenelzine shows promise for treating recurrent prostate cancer

Phase I preliminary data presented for ACTUS-101 in late-onset Pompe disease

The Year's New Drugs & Biologics reviews 2019's new drugs and candidates for 2020 approval

FDA approves Twirla contraceptive patch

Beovu approved in E.U. for wet AMD

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 29, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 29, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...